Dr Michael Dho Spangfort

Ph.D. (Biochem., MBA), Managing Director, Nobel Biosolutions Hong Kong

Michael has spent 15 years in Hong Kong travelling extensively in China for first ALK A/S a Danish allergy focus specialty pharma and diagnostic company. He has extensive knowledge of NMPA regulatory affairs, local clinical trials and product approvals.

Michael was previous Global Director Research at ALK managing strategic partnerships with biotech and pharma companies. He established a R&D Lab in Guangzhou and managed the development of an independent diagnostic business unit.

During his time in Hong Kong Michael have carried out Market Access studies covering China, Taiwan and South Korea as well as managed collaboration with Japanese Pharma companies.

The last 4 years the main client has been Thermo Fisher Immunodiagnostic division helping getting their products approved and commercialised in China.

Michael has a Ph.D. in Biochemistry from Lund University, Post Doctor fellowship in structural biology at Max Planck Institute of Biophysics, Frankfurt and Executive MBA, Univ. of Lund. Michael has published 69 peer reviewed article and is listed on 4 patents.

MichaelSpandgfort 2016